Clinical Trial Update: PINPOINT: Gaming Technology for SCD Pain [NA]

View source ↗

Summary

A completed clinical trial evaluated PINPOINT gaming technology for pain management in sickle cell disease; results were posted on May 1, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Sickle Cell Disease with Hemoglobin Sc
• Sickle Cell Thalassemia

Snippet

Sponsor: Klein Buendel, Inc. | Conditions: Sickle Cell Disease, Sickle Cell Anemia in Children | NA | Status: COMPLETED | Results posted: 2024-05-01